Share Market HIGHLIGHTS: Sensex finishes 571 pts lower, Nifty slips to 19,742; M&M, ICICI Bank drop 3%

Written By: ZeeBiz WebTeam Updated on: September 21, 2023, 04.31 PM IST

Share Market HIGHLIGHTS: Domestic equity benchmarks Nifty 50 and Sensex tumbled for the third consecutive session on Thursday, September 21. Catch minute-by-minute updates of all the action in the Indian share market today, market commentary and analysis, the views of Zee Business Managing Editor Anil Singhvi and other experts, stocks to buy and trade recommendations only on Zeebiz.coms blog.

Share Market HIGHLIGHTS: Domestic equity benchmarks Nifty 50 and Sensex tumbled for the third consecutive session on Thursday, September 21, after the US Federal Reserve signalled that interest rates could stay higher for longer. Auto, bank, pharma, financial services, and realty counters were down over 1 per cent.

At close, the S&P BSE Sensex was down 570.6 points, or 0.85 per cent, at 66,230.24, and the NSE Nifty was down 159.05 points, or 0.8 per cent, at 19,742.35. In the broader market, the Nifty Mid Cap 100 and Small Cap 100 indices also fell and ended in negative territory. Nifty Bank settled at 44,623.85, 1.68 per cent lower.

Catch minute-by-minute updates of all the action in the Indian share market today, market commentary and analysis, the views of Zee Business Managing Editor Anil Singhvi and other experts, stocks to buy and trade recommendations only on Zeebiz.com's blog:

Latest Updates

  • Thank you! That's all today on Zeebiz.com's blog on the Indian share market

    For all other news related to business, politics, tech, sports and auto, follow us on TwitterFacebookLinkedIn and Instagram

  • Share Market HIGHLIGHTS | Sensex finishes 571 pts lower, Nifty slips to 19,742

    Nifty 

    Nifty slips to 19,742, down 0.8 per cent.

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    Source: NSE

    Sensex

    Sensex finishes 571 points lower at 66,230.24.

    Source: BSE

  • Share Market HIGHLIGHTS | M&M, ICICI Bank, Cipla emerge as top losers in 50-scrip blue-chip basket

    M&M, ICICI Bank, Cipla and SBI are among the top losers in the Nifty basket, down nearly 3-2 per cent. On the other hand, Adani Ports, TechM, Dr Reddy's and Asian Paints are among the top gainers, trading with gains of around 2-1 per cent.

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    Source: NSE

  • Share Market Today LIVE | Glenmark, KSB, other stocks hit 52-week highs

    Amid selling in benchmark indices, as many as eight stocks in the BSE 500 basket — the broadest index on the bourse — reached the milestone.

    Stock CMP 52 Weeks High Previous 52 Weeks High(Price/Date) All Time High(Price/Date)
    CHOLAHLDNG 1,208.05 1,282.75 1,194.00 (14 Sep 2023) 1,282.75 (21 Sep 2023)
    GLENMARK 829 879.15 872.95 (15 Sep 2023) 1,261.95 (21 Aug 2015)
    INDIANB 402.95 427.95 424.05 (18 Sep 2023) 428.00 (17 Nov 2017)
    KIOCL 319.75 357.85 322.00 (20 Sep 2023) 506.45 (14 Nov 2017)
    KSB 3,030.90 3,085.35 2,919.90 (07 Sep 2023) 3,085.35 (21 Sep 2023)
    PHOENIXLTD 1,810.25 1,907.20 1,901.40 (11 Sep 2023) 37,536.25 (21 Sep 2005)
    POLYCAB 5,223.00 5,357.55 5,331.00 (06 Sep 2023) 5,357.55 (21 Sep 2023)
    WELCORP 392.05 406.7 404.30 (20 Sep 2023) 537.70 (17 Jan 2008)
  • Nifty Today LIVE | ICICI Bank, RIL, HDFC Bank, SBI, ITC among top drag in Nifty 50 basket

    Source: NSE

  • Share Market Today LIVE |Zydus Lifesciences shares extend losses to third day; is there any opportunity?

    Zydus Lifesciences shares gave up initial gains amid volatile trade on Thursday, mirroring an overall weak session on Dalal Street. The Zydus Lifesciences stock decline by as much as Rs 7.4, or 1.2 per cent, to Rs 617.1 apiece on BSE, continuing to fall for the third session in a row. The pharmaceutical company received final approval from the US drug regulator, the US Food and Drug Administration, for its clindamycin phosphate gel, used in the treatment of acne. Clindamycin is an antibiotic which works by stopping the growth of bacteria. In a regulatory filing post-market hours on Wednesday, the company said the drug will be manufactured at the group’s topical manufacturing facility at Changodar in Ahmedabad. Read more

  • Share Market Today LIVE | Nifty Bank trades over 550 pts higher amid weakness in benchmark indices 

    Source: NSE

  • Share Market Today LIVE | Morgan Stanley sees 19% upside in this stock, which has gained over 200% in a year

    Global brokerage firm Morgan Stanley is bullish on Kaynes Technology India, an integrated electronics manufacturer, which has given a return of over 203 per cent in a year. The brokerage has initiated an 'overweight' rating on the stock and sees an upside potential of nearly 19 per cent from Wednesday's closing.

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    In its report, Morgan Stanley has stated that India plays a vital role in electronic manufacturing and has estimated the revenue growth of the segment at a 21 per cent compound annual growth rate (CAGR) by FY22–32. It believes that by FY32, the revenue will grow to $604 billion. Read more 

     

  • Share Market Today LIVE | HDFC AMC shares jump after RBI's nod to acquire up to 9.5% stake in Karur Vysya Bank and DCB Bank

    The stock of HDFC AMC trades 0.35 per cent lower, at Rs 2,675 on a day when the RBI approved the mutual fund company to acquire up to 9.5 per cent stake in Karur Vysya Bank and DCB Bank each.  

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    "The RBI has accorded its approval to HDFC Asset Management Company Ltd. (HDFC AMC) for acquiring aggregate holding of up to 9.5% of the paid-up share capital or voting rights of The Karur Vysya Bank Ltd. The approval has been granted with reference to the application made by HDFC AMC to RBI," Karur Vysya Bank said in a statement. Read more 

     

     

  • Share Market Today LIVE | Sensex tanks over 600 pts amid weakness in broad-based market selling

    Source: BSE

  • Share Market Today LIVE | REC shares shrug off weakness on D-Street; what is driving the infra financier stock?

    Rural Electrification Corporation (REC) shares are in high demand in an otherwise weak market on Thursday after a subsidiary of the state-run infrastructure finance company transferred its Beawar Transmission to Sterlite Grid 27, and incorporated a new wholly-owned subsidiary. The REC stock jumps by as much as Rs 7.85, or 3.09 per cent, to Rs 262.3 apiece on BSE after the announcements. In a regulatory filing post-market hours on Wednesday, REC said its wholly-owned subsidiary REC Power Development & Consultancy transferred its entire shareholding of 50,000 shares in Beawar Transmission along with its assets and liabilities to Sterlite Grid 27 on the same day. Read more 

     

  • Share Market Today LIVE | Apollo Tyres shares decline 3% on disruption of operations at Limda plant

    Shares of Apollo Tyres decline after the company, in its regulatory filing on September 20, informed bourses that Bias and OTR tyre production at its manufacturing facility in Limda, Gujarat, has been stopped due to certain concerns amongst shop floor employees relating to the renewal of a long-term settlement agreement. Apollo Tyres further said that the company was in discussions and negotiations with the labour union representatives to address their concerns and find an amicable resolution. The counter trades 
    at Rs 369.75, down 2.43 per cent on NSE. 
    Read more 

     

  • Share Market Today LIVE | Fino Payments Bank receives complaints about misappropriation of funds; stock slips over 8%

    Shares of Fino Payments Bank, a commercial banking company, slips as much as 8 per cent, touching the day's low of Rs 304.5 apiece on Thursday, September 21. The selling pressure in the scrip came after the bank said it had received complaints from one of its clients regarding misappropriation of funds, cheating, and forgery. Read more 

     

  • Share Market Today LIVE | EMS Limited lists at 34% premium over issue price

    The shares of EMS Limited list at around Rs 280, up 33 per cent over its issue price of Rs 211, on the NSE. Whereas, the counter debuts at Rs 281.55 on BSE.

    Source: NSE

  • Share Market Today LIVE | SJVN's two-day OFS opens today; shares tank around 10 per cent

    Shares of SJVN tanks, a day after the state-owned power producer informed bourses that the government will sell a 4.92 per cent stake in SJVN through a two-day offer for sale, starting today. The shares fell as much as nearly 10 per cent to touch the day's low of Rs 73.6 on the NSE. The floor price for OFS of the hydroelectric power generation and transmission company has been fixed at around Rs 69 apiece, which is a 16 per cent discount to the last market price.

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    DIPAM Secretary Tuhin Kanta Pandey on X said, "Offer for sale in SJVN opens tomorrow for non-retail investors. Retail investors can bid on Friday. The government will divest 4.92 per cent of equity, including a Green Shoe option of 2.46 per cent."

     

  • Anil Singhvi Market Strategy | Important levels to track in Nifty, Nifty Bank today

    Zee Business Managing Editor Anil Singhvi sees support for the headline Nifty index emerging at 19,725-19,825 levels and a strong base at 19,550-19,650 levels on Thursday, September 21. For the Nifty Bank, he expects support at 45,000-45,150 levels and a strong base at 44,825-44,950 levels.

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    Read more on how Anil Singhvi views the Indian share market today and what he recommends

     

  • Share Market Today LIVE | Nifty below 19,850, Sensex drop over 300 pts

    Nifty 

    Nifty trades below 19,850, down 0.31 per cent in opening deals.

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    Source: NSE

    Sensex

    Sensex drop over 300 points, down 0.46 per cent in opening deals.

     

    Source: BSE

  • Dividend, Bonus stocks | PFC, Gufic Biosciences, Career Point, other stocks to trade ex-date

    BSL dividend

    BSL has announced a dividend of Rs 1.5 per equity share with a face value of Rs 10.

    PFC bonus share record date 2023

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    Power Finance Corporation will trade ex-bonus date today, in the ration of 1:4. September 21 has also been fixed as record date. 

    Gufic Biosciences dividend

    Gufic Biosciences has announced a dividend of Re 0.1 per equity share with a face value of Re 1. Read more 

     

  • Pre-Opening Market Comment | Prashanth Tapse, Senior VP (Research), Mehta Equities Ltd

    “A rough start to the trading session is on the cards as overnight weakness in the US markets has triggered a slump in other Asian counterparts after the US Federal Reserve hinted at a one more rate hike by the end of this year even as it kept rates unchanged in its FOMC meeting yesterday. Another negative catalyst has been frenzied selling by foreign institutional investors as they sold shares worth Rs 3110.69 crores in the domestic equity markets on Wednesday, which could further dampen the sentiment. The firm US Dollar index and treasury yields are also driving FIIs to desert emerging market equities.”

  • Stocks to Watch | Infosys, Zydus Lifesciences, Biocon, Godrej Properties, EMS Ltd, Cipla and Apollo Tyres among top stocks to track today

    Infosys

    COMMERCIAL BREAK
    SCROLL TO CONTINUE READING

    IT company Infosys plans to train and certify 50,000 employees on NVIDIA AI technology to provide expertise to its customers across industries, the company said on Wednesday. The development follows the expansion of collaboration between Infosys and chipset company NVIDIA to provide generative AI-based solutions to enterprises worldwide. "Infosys plans to set up an NVIDIA Centre of Excellence, where it will train and certify 50,000 of its employees on NVIDIA AI technology to provide generative AI expertise to its vast network of customers across industries," Infosys and NVIDIA said in a joint statement.

    EMS

    The company's shares are slated to debut on bourses today. 

    Apollo Tyres

    In its regulatory filing, the company said that Bias and OTR tyres production at its manufacturing facility in Limda, Gujarat, has been stopped due to certain concerns amongst shop floor employees relating to the renewal of the long-term settlement agreement.

    Biocon

    Biocon Biologics Ltd., a subsidiary of Biocon Ltd, has announced that the European Commission (EC) granted marketing authorization in the European Union (EU) for YESAFILI®, a biosimilar of Aflibercept.

    Zydus Lifesciences

    Zydus Lifesciences Limited said on Wednesday that it had received final approval from the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Gel USP, 1 per cent (USRLD: Cleocin T Gel, 1 per cent). Clindamycin Phosphate Gel USP, 1 per cent, is used to treat acne. "The drug will be manufactured at the group’s topical manufacturing facility at Changodar, Ahmedabad (India)," the company said in a filing. Clindamycin Phosphate Gel USP, 1 per cent, had annual sales of $37 million in the United States. Read more

  • Share Market Today LIVE | GIFT Nifty futures indicate a weaker opening ahead on D-Street

    GIFT Nifty futures — an early indicator of the Nifty 50 index — are down 128.85 points or 0.65 per cent at 19,843 ahead of the opening bell on Dalal Street.

  • Good morning! Welcome to Zeebiz.com's blog on the stock market today

    Follow this space to catch minute-by-minute market action, the views of Zee Business Managing Editor Anil Singhvi  and other experts, investment ideas, stock picks, brokerage calls and much more through the day. 

    Happy trading, and happy investing!

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

ZEEBIZ TRENDING STORIES